BORDEAUX, France--(BUSINESS WIRE)--FineHeart S.A, a clinical-stage medtech company developing breakthrough solutions for cardiology, is pleased to announce the appointment of André-Jacques Auberton-Hervé to its Board of Directors.

法国波尔多--（商业新闻短讯）--FineHeart S.A是一家临床阶段的医疗技术公司，正在开发突破性的心脏病学解决方案，很高兴宣布任命安德烈·雅克·奥伯顿·埃尔维为董事会成员。

The arrival of André-Jacques Auberton-Hervé marks a crucial step in FineHeart's development, confirming its determination to play a key role in the implantable cardiology medical device industry, at a time when the company is successfully rolling out its clinical program in Europe and preparing to expand its global presence..

安德烈·雅克·奥伯顿·埃尔维的到来标志着Finehart发展的关键一步，这证实了其决心在植入式心脏病医疗器械行业发挥关键作用，而此时该公司正在欧洲成功推出其临床项目，并准备扩大其全球影响力。。

A former co-founding Chairman of SOITEC, which he led for 23 years to world leadership in semiconductors, André-Jacques Auberton-Hervé is renowned for his passion for disruptive technological innovations and his ability to turn them into commercial successes.

安德烈·雅克·奥伯顿·赫维是SOITEC的前联合创始人之一，他领导SOITEC长达23年，在半导体领域处于世界领先地位，他以对颠覆性技术创新的热情和将其转化为商业成功的能力而闻名。

“I am delighted to welcome André-Jacques to the Board at this key moment in the company's development. His rich and successful experience in creating and leading innovative companies to success will be of invaluable value for FineHeart' declared Jean-Luc Boulnois, Executive Chairman of FineHeart's Board of Directors..

“在公司发展的关键时刻，我很高兴欢迎安德烈·雅克（André-Jacques）加入董事会。他在创建和领导创新型公司取得成功方面的丰富而成功的经验将对FineHeart具有宝贵的价值”，FineHeart董事会执行主席让-吕克·布尔诺瓦（Jean-LucBoulnois）表示。。

'I'm impressed by the remarkable scientific advance by FineHeart's team and it’s FlowMaker's breakthrough technology. I am convinced of its immense potential to treat advanced heart failure, an area where no major innovation has seen the light of day for decades, and where the medical needs are huge.

“Finehart团队取得的显著科学进步以及FlowMaker的突破性技术给我留下了深刻印象。我相信它在治疗晚期心力衰竭方面具有巨大潜力，几十年来，这一领域没有重大创新，医疗需求巨大。

I’m looking forward to working alongside the board and with the whole team in driving forward FineHeart’s scale up', said André-Jacques Auberton-Hervé..

安德烈·雅克·奥伯顿·埃尔维（André-JacquesAuberton-Hervé）说：“我期待着与董事会和整个团队一起努力，推动FineHeart的规模扩大。”。。

Arnaud Mascarell, CEO and co-founder of FineHeart, continues: 'The exceptional career of André-Jacques, a visionary industrialist, is inspirational for the whole team. We sincerely thank him for the trust he has placed in us and look forward to collaborate to supporting FineHeart in its next phases of development'..

FineHeart首席执行官兼联合创始人阿诺·马斯卡雷尔（ArnaudMascarell）继续说道：“安德烈·雅克（André-Jacques）是一位富有远见的实业家，他出色的职业生涯对整个团队来说都是鼓舞人心的。我们衷心感谢他对我们的信任，并期待着合作支持FineHeart的下一个发展阶段。。

André-Jacques Auberton-Hervé co-founded Soitec in 1992. For 23 years, as Chairman and CEO, he directed the strategic, operational and financial activities of the company, which he raised to the rank of world leader in semiconductors. He built an international high-tech group, present in 10 countries, with 5 production sites in Europe, Asia and the United States.

安德烈·雅克·奥伯顿·埃尔维于1992年与人共同创立了Soitec。23年来，他担任董事长兼首席执行官，负责公司的战略、运营和财务活动，并将其提升为半导体领域的世界领导者。他建立了一个国际高科技集团，目前分布在10个国家，在欧洲、亚洲和美国拥有5个生产基地。

The company, which he floated on Euronext in 1999, is now valued at over $5 billion..

该公司于1999年在泛欧交易所上市，目前价值超过50亿美元。。

André-Jacques Auberton-Hervé has been a member of the European Commission's Key Enabling Technologies group since 2010, bringing together European industrial and academic experts tasked with developing a common long-term strategy for technologies such as nanoelectronics, nanotechnologies, photonics, advanced materials and biotechnology..

安德烈·雅克·奥伯顿·埃尔维（André-Jacques Auberton Hervé）自2010年以来一直是欧盟委员会关键扶持技术小组的成员，汇集了欧洲工业和学术专家，负责制定纳米电子学、纳米技术、光子学、先进材料和生物技术等技术的共同长期战略。。

He was a member of the Board for 12 years and Chairman of the global association of semiconductor industry players SEMI from 2013 to 2015.

2013年至2015年，他担任了12年的董事会成员和全球半导体行业参与者协会主席。

Highly involved in the emergence and structuring of innovative industries, he sits on the board of several international companies. He contributes to the financing and governance of fast-growing companies in sectors such as digital imaging (Enlaps) and MicroLED displays based on Aledia nanowires. He is an ambassador for Clinatec, the world's only clinical research center in the field of neuroscience, which brings together on a single site all the players involved in innovation in micro-nanosystems for healthcare, from clinicians and biologists to technologists.

他高度参与创新产业的出现和构建，是几家国际公司的董事会成员。他为数字成像（Enlaps）和基于Aledia纳米线的MicroLED显示器等领域快速增长的公司的融资和治理做出了贡献。他是Clinatec的大使，Clinatec是世界上唯一一个神经科学领域的临床研究中心，它汇集了从临床医生、生物学家到技术专家在内的所有参与医疗保健微纳米系统创新的参与者。

André-Jacques Auberton-Hervé is an engineer with a doctorate in physics from Ecole Centrale Lyon (France). .

安德烈·雅克·奥伯顿·埃尔维（André-Jacques Auberton Hervé）是一名工程师，拥有里昂中央高等专科学校（法国）物理学博士学位。。